Prostate adenocarcinoma is a medical condition with active clinical research programs worldwide.

15 total trials for this combination

Showing top 10 of 15 trials

Trials

NCT ID	Title	Status	Phase
NCT04423211	Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging	RECRUITING	PHASE3
NCT06235151	Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer	RECRUITING	PHASE3
NCT03821246	Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy	RECRUITING	PHASE2
NCT04513717	Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial	ACTIVE_NOT_RECRUITING	PHASE3
NCT03739684	Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer	COMPLETED	PHASE3
NCT06235099	Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer	COMPLETED	PHASE3
NCT05050084	Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial	RECRUITING	PHASE3
NCT05946213	Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer	RECRUITING	PHASE3
NCT04134260	Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial	RECRUITING	PHASE3
NCT03274687	Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer	ACTIVE_NOT_RECRUITING	PHASE3

Related Pages

All Prostate adenocarcinoma trials All trials in St. Louis, United States